课题基金 / 基金详情

Kits to Quantitate and Analyze Mitochondrial Proteins

Kits to Quantitate and Analyze Mitochondrial Proteins
定量和分析线粒体蛋白的试剂盒
批准号:
6787462
负责人:
Michael F Marusich
金额:
$14.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-07 至 2005-05-31

项目摘要

项目成果

Michael F Marusich的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):线粒体在细胞能量代谢中起着关键作用:它们是氧化磷酸化(OXPHOS)的所在地,它产生哺乳动物细胞所利用的98%的ATP。OXPHOS由5个大的、膜结合的、由90个多肽组成的蛋白质复合物催化。底物进入OXPHOS系统是由第六种大型酶复合物丙酮酸脱氢酶复合物控制的。这六种复合体的遗传缺陷导致一系列异质的人类疾病,这些疾病被统称为线粒体疾病,每6000个活产婴儿中就有1个受到影响。线粒体疾病仍然难以诊断,这些疾病的基因型-表型关系仍然模糊不清。线粒体功能障碍被认为是一些迟发性疾病的病因和/或预测因素,包括帕金森病、阿尔茨海默病、早发性和晚发性糖尿病、精神分裂症和某些形式的心脏病。所有这些病症的共同点是,它们是由氧化损伤的积累引起的,氧化损伤导致细胞死亡,这是由线粒体引起的,特别是OXPHOS成分。与线粒体遗传疾病一样,上述迟发性疾病的病因尚不清楚,诊断也很困难,因为缺乏足够的、简单的高通量方法来分析OXPHOS组分的组成、酶活性和翻译后(氧化)修饰。这笔拨款是为了建立基于免疫学的分析方法。单克隆抗体(mab)已经从少量的人和其他哺乳动物组织中产生,这些单克隆抗体捕获了50XPHOS复合物和丙酮酸脱氢酶的4种功能活跃的完整形式。目前正在筛选捕获复合物III的单抗。这些将被制作成几个96孔为基础的微分析。将通过双染料荧光法比较实验/诊断样品与对照样品中每种复合物的水平。第二种方法是使用荧光和比色活性测定法比较实验样品中每个复合物的酶活性与对照。第三组将免疫捕获各种复合物,其数量足以用于翻译后修饰的蛋白质组学分析。这些试剂盒不仅对研究早发性和晚发性线粒体疾病的研究人员,而且对线粒体生理学的研究,以及对引起这些疾病的环境毒素和改善这些疾病的药物的高通量筛选,都将是无价的。
英文摘要
DESCRIPTION (provided by applicant): Mitochondria play a key role in cellular energy metabolism: they are the seat of oxidative phosphorylation (OXPHOS), which produces 98 percent of all the ATP utilized by mammalian cells. OXPHOS is catalyzed by 5 large, membrane-bound, protein complexes together made up of 90 polypeptides. Substrate entry into the OXPHOS system is controlled by a sixth, large enzyme-complex, the pyruvate dehydrogenase complex. Genetic defects in these six complexes cause a heterogeneous set of human diseases collectively classified as mitochondrial disorders, which affect around 1 in 6000 live births. Mitochondrial diseases remain hard to diagnose and the genotype-phenotype relationships of these disorders is still obscure. There are several late-onset diseases where mitochondrial dysfunction is thought to be causal and/or predictive, including Parkinson's disease, Alzheimer's, early- and late-onset Diabetes, schizophrenia and some forms of heart disease. In common to all of these conditions is the idea that they result from accumulation of oxidative damage leading to cell death caused by and involving the mitochondrion and the OXPHOS components in particular. As with mitochondrial genetic diseases, the etiology of the late-onset diseases listed above remains obscure and their diagnosis is still difficult because of a lack of adequate, simple high-throughput methods for analyzing the composition, enzyme activities and post-translational (oxidative) modifications of the OXPHOS components. This grant is to establish immunologically-based methods for such analyses. Monoclonal antibodies (mAbs) have been generated from small amounts of human and other mammalian tissue, which capture functionally active intact forms of 4 of the 50XPHOS complexes and pyruvate dehydrogenase. Screening is in progress for a mAb to capture Complex III. These will be fabricated into several 96-well based microassays. One will compare the levels of each complex in an experimental/ diagnostic sample versus a control sample by a twodye fluorometric approach. A second will compare the enzymatic activities of each complex in an experimental sample with a control using fluorometric and colorimetric activity assays. A third set will immunocapture the various complexes in amount sufficient for proteomic analysis of post-translational modifications. These kits will be invaluable, not only for researchers studying early-onset and late-onset mitochondrial disorders, but also for studies of mitochondria physiology, and for high-throughput screening for environmental toxins that cause, and drugs that ameliorate, these conditions.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Simultaneous Diagnosis of Dengue and Prognosis of Severe Dengue with a Single Point-of-Care Test
  • 批准号:
    10475305
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2021
  • 负责人:
    Michael F Marusich
  • 依托单位:
Simultaneous Diagnosis of Dengue and Prognosis of Severe Dengue with a Single Point-of-Care Test
  • 批准号:
    10324527
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    Michael F Marusich
  • 依托单位:
Mitochondrial dysfunction in HAART: Point of care tests
  • 批准号:
    6893169
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2005
  • 负责人:
    Michael F Marusich
  • 依托单位:
Mitochondrial Dysfunction in HAART: Point of Care Tests
  • 批准号:
    7423846
  • 项目类别:
  • 资助金额:
    $59.15万
  • 财政年份:
    2004
  • 负责人:
    Michael F Marusich
  • 依托单位:
海外基金